Table 6.
Description of unjustified ciprofloxacin prescriptions
Unjustified cipro prescription n (%) | |||
---|---|---|---|
With bacteriological finding |
10 (37.0) |
||
|
P. aeruginosa |
4 |
|
|
|
Intravenous cipro |
4 |
|
|
Site of infection for P. aeruginosa# |
4 |
|
Multiply susceptible E. coli |
1 |
|
|
ESBL producing E. coli |
1 |
|
|
CNS |
|
4 |
|
|
Intravenous cipro |
1 |
|
|
Oral cipro |
5 |
|
|
Site for non-P. aeruginosa infections$ |
|
Unjustified by antibiogram results |
6 |
||
Unjustified by intravenous cipro in susceptible P. aeruginosa infection |
4 |
||
Without bacteriological finding |
17 (63.0) |
||
|
Site of non bacteriologically-documented infection |
12 |
|
|
|
Pulmonary |
7 |
|
|
Abdominal |
2 |
|
|
Catheter related infection |
1 |
|
|
Operative site infection |
1 |
|
|
Prophylaxis |
1 |
|
Empiric therapy for fever |
5 |
|
|
|
Neutropenia |
1 |
|
|
Immunocompromised but without Neutropenia |
4 |
Unjustified by clinical situation |
17 |
||
Total | 27 (100) |
# 2 pulmonary and 2 catheter related infection.
$ 2 pulmonary, 2 urinary and intra-abdominal, mediastinitis each.